Effect of Non-surgical Periodontal Treatment on Oxidative Stress and Antioxidant Status in OSAS
OSAS
1 other identifier
interventional
40
1 country
1
Brief Summary
The main objective of this study is to compare the effect of the non-surgical periodontal treatment on serum and saliva oxidative stress parameters in patients with periodontitis and obstructive sleep apnea syndrome (OSAS) and in patients with periodontitis only.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jul 2017
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 1, 2017
CompletedFirst Submitted
Initial submission to the registry
August 22, 2017
CompletedFirst Posted
Study publicly available on registry
August 31, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
November 1, 2023
CompletedFebruary 28, 2024
February 1, 2024
6.1 years
August 22, 2017
February 27, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (10)
Serum Total Antioxidant Status (TAS) level (millimolar per liter (mmol /L))
Changes in serum and salivary oxidative stress parameters
3 months
Serum Total Oxidant Status (TOS) level (mikromolar per liter (µmol /L))
Changes in serum and salivary oxidative stress parameters
3 months
Serum Oxidative Stress Index (OSI) level : TOS/TAS
Changes in serum and salivary oxidative stress parameters
3 months
Serum Native Thiol (mikromolar per liter (µmol /L))
Changes in serum and salivary oxidative stress parameters
3 months
Serum Thiol/disulfid (millimolar per liter (mmol /L))
Changes in serum and salivary oxidative stress parameters
3 months
Saliva Total Antioxidant Status (TAS) level (millimolar per liter (mmol /L))
Changes in serum and salivary oxidative stress parameters
3 months
Saliva Total Oxidant Status (TOS) level (mikromolar per liter (µmol /L))
Changes in serum and salivary oxidative stress parameters
3 months
Saliva Oxidative Stress Index (OSI) level : TOS/TAS
Changes in serum and salivary oxidative stress parameters
3 months
Saliva Native Thiol (mikromolar per liter (µmol /L))
Changes in serum and salivary oxidative stress parameters
3 months
Saliva Thiol/disulfid (millimolar per liter (mmol /L))
Changes in serum and salivary oxidative stress parameters
3 months
Secondary Outcomes (5)
Plaque Index (PI)
3 months
Gingival Index (GI)
3 months
Bleeding on probing (BOP)
3 months
Clinical attachment loss(CAL)
3 months
Probing pocket depth (PD)
3 months
Study Arms (2)
Experimental: Non-surgical periodontal therapy in patient with OSAS and Periodontitis
EXPERIMENTALNon-surgical periodontal therapy consisted of scaling and root planing and supportive periodontal therapy during 3 months Individuals: with both OSAS and periodontitis Intervention: Procedure: Non-surgical periodontal therapy
Control: non-surgical periodontal therapy in Periodontitis
ACTIVE COMPARATORNon-surgical periodontal therapy consisted of scaling and root planing and supportive periodontal therapy during 3 months Individuals: only periodontitis Intervention: Procedure: Non-surgical periodontal therapy
Interventions
Experimental: Non-surgical periodontal therapy in patient with OSAS and Periodontitis
Control: Non-surgical periodontal therapy in Periodontitis
Eligibility Criteria
You may qualify if:
- aged ≥18 years old
- having more than 16 teeth
- BMI\>25 kg/m2
You may not qualify if:
- patients with a history of diabetes mellitus or respiratory diseases
- patients who were under any medication that was known to influence periodontal tissues
- patients with a history of any periodontal treatment in the past 6 months
- patients with hormonal changes such as pregnancy or lactation; and 5) patients having fixed dentures or removable prothesis
- OSAS treatment started (using OSAS therapy device or undergoing surgical operation)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Bezmialem Vakıf University, Faculty of Dentistry, Deparment of Periodontology,
Istanbul, 34093, Turkey (Türkiye)
Related Publications (3)
Loke W, Girvan T, Ingmundson P, Verrett R, Schoolfield J, Mealey BL. Investigating the association between obstructive sleep apnea and periodontitis. J Periodontol. 2015 Feb;86(2):232-43. doi: 10.1902/jop.2014.140229. Epub 2014 Oct 9.
PMID: 25299385BACKGROUNDGamsiz-Isik H, Kiyan E, Bingol Z, Baser U, Ademoglu E, Yalcin F. Does Obstructive Sleep Apnea Increase the Risk for Periodontal Disease? A Case-Control Study. J Periodontol. 2017 May;88(5):443-449. doi: 10.1902/jop.2016.160365. Epub 2016 Nov 18.
PMID: 27858556RESULTDPTT study group; Engebretson S, Gelato M, Hyman L, Michalowicz BS, Schoenfeld E. Design features of the Diabetes and Periodontal Therapy Trial (DPTT): a multicenter randomized single-masked clinical trial testing the effect of nonsurgical periodontal therapy on glycosylated hemoglobin (HbA1c) levels in subjects with type 2 diabetes and chronic periodontitis. Contemp Clin Trials. 2013 Nov;36(2):515-26. doi: 10.1016/j.cct.2013.09.010. Epub 2013 Sep 27.
PMID: 24080100RESULT
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Zeliha Betul Özsağır
Bezmialem VU
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 22, 2017
First Posted
August 31, 2017
Study Start
July 1, 2017
Primary Completion
August 1, 2023
Study Completion
November 1, 2023
Last Updated
February 28, 2024
Record last verified: 2024-02
Data Sharing
- IPD Sharing
- Will not share